Parecoxib sodium alleviates ischemia reperfusion‐induced pulmonary injury via inhibiting ERK/NF‐κB and further activating the HIF‐1α pathway

INTRODUCTION: The lungs are extremely vulnerable to ischemia/reperfusion (I/R), which is characterized by intense inflammation, oxidative stress, alveolar damage, and vascular permeability. Parecoxib sodium (Pare) has been shown to exert protective effects against multiple I/R‐induced tissue injurie...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiantao, Yang, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382860/
https://www.ncbi.nlm.nih.gov/pubmed/36039646
http://dx.doi.org/10.1002/iid3.684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382860/
https://www.ncbi.nlm.nih.gov/pubmed/36039646
http://dx.doi.org/10.1002/iid3.684

Ejemplares similares